Biostage Program Organ Regeneration

Share this article with:

About 456,000 new cases of esophageal cancer occur each year. In the United States alone, there are 17,000 new cases. Esophageal cancer is treated with an esophagectomy, which has a 90-day mortality rate as high as 19%. Biostage is pioneering a new technology to regenerate the patient’s native esophasgus through Cellframe Technology. Two weeks before the esophagectomy, stem cells are extract and incubated with the Cellspan implant in a bioreactor. This animation shows how Cellframe Technology works to regenerate esophagus tissue and muscle through stem cells as well as the Cellspan Implant process.

Share It:
Contact XVIVO


Biostage Program Organ Regeneration

We have only positive feedback for you and your team. This experience has been great and trouble-free from the beginning. I would not hesitate to refer another company to XVIVO should they need help with scientific and medical illustration. Thanks for the great work.

Operations Manager, C3 Jian